Search images on Google Product Monograph
Active Ingredients:
- brodalumab, 210 MG/1.5 ML
DIN: 02473623
Dosage Form(s): SOLUTION
Route(s) of Administration: SUBCUTANEOUS
Description: 2 SINGLE USE PREFILLED SYRINGES
Schedule: Schedule D
Company: BAUSCH HEALTH, CANADA INC.
ATC:
- L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
- L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
- L04AC - Interleukin inhibitors (ATC, WHO)
- L04AC12 - BRODALUMAB (WHO)
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 2X1.5ML